Costco options sentiment shifts as analysts trim targets post-earnings

The Street told a more nuanced story after the September results. The broad direction was downward on targets, without touching ratings. JP Morgan's Christopher Horvers trimmed to $1,015 from $1,100 while keeping Overweight. Raymond James cut to $1,050 from $1,100 at Outperform. Deutsche Bank moved to $1,079 from $1,091, Buy intact. The lone dissenter on direction was DA Davidson, which actually raised its Neutral target to $1,040 from $1,000. The mean target across the analyst universe stands near $1,058, implying roughly 13% upside from the current $935.68. The bull case centres on the membership flywheel: 92.3% domestic renewal rates, a 60% surge in younger members and expanding pharmacy and delivery channels. Bears point to tariff cost pressure, $7.5bn in planned FY27 capex, slowing paid member growth of 3.8% year-on-year, and a valuation that still demands execution. At 38x trailing earnings and an EV/EBITDA of 23.5x, the factor score on value ranks in the 6th percentile. EPS momentum, by contrast, ranks at the 90th percentile over 30 days and 84th over 90 days, which has kept the bull thesis coherent despite the multiple. Analyst recommendation divergence ranks in the 93rd percentile, meaning the spread between bullish and neutral views is unusually wide.

Wikipedia attention for Costco has ticked above its 90-day average, with a z-score of 1.18 as of late September, suggesting retail interest in the stock is running somewhat higher than usual. There are no alt-data datasets with a measured lead to the company's financials in the current coverage, so that reading is colour rather than a forward signal.

On ownership, the picture is passive and incrementally positive. BlackRock holds 7.72% of shares and added 87,000 shares in the most recent quarter. State Street added 233,000 shares. The insider activity is less encouraging: two executive vice presidents, Claudine Adamo and Caton Frates, made discretionary open-market sales totalling roughly $2.75 million in net value over the trailing 90 days. Neither sale was filed under a 10b5-1 plan, which is worth noting even if the amounts are modest relative to the company's scale. The September 10 activity was compensation-related grants offset by tax-withholding sales, not open-market conviction.

With the next earnings print 64 days away on December 10, the setup to watch is whether the shift toward calls in options markets holds, or whether the stock's premium multiple draws renewed hedging demand as the quarter progresses and tariff and capex headlines accumulate.